CMMB Q4 2018 Earnings — Chemomab Therapeutics Ltd. Revenue & Financial Results | Market Cap Arena

CMMBChemomab Therapeutics Ltd.

$12M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$19,864

Operating Income

-$3M

Net Income

-$2M

EPS (Diluted)

$-9.23

QoQ Revenue Growth

NaN%

Balance Sheet

Total Assets

-$15M

Total Liabilities

$0

Stockholders' Equity

$0

Cash & Equivalents

-$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$19,864	-$14,877	-33.5%
Operating Income	-$3M	-$2M	-56.2%
Net Income	-$2M	-$2M	+8.3%